XML 30 R17.htm IDEA: XBRL DOCUMENT v3.20.2
Income Tax Expense
12 Months Ended
Sep. 30, 2020
Income Tax Expense  
Income Tax Expense

8.      Income Tax Expense

Total income tax expense (benefit) for the years ended September 30, 2020, 2019 and 2018 was allocated to income tax expense as follows:

(Dollars in thousands)

    

2020

    

2019

    

2018

Income tax expense (benefit) from continuing operations

$

14,278

 

20,388

 

(5,170)

Income tax expense from discontinued operations

 

23,501

 

789

 

1,060

Total income tax expense (benefit)

$

37,779

 

21,177

 

(4,110)

The components of income from continuing operations before income taxes for 2020, 2019 and 2018 consisted of the following:

(Dollars in thousands)

    

2020

    

2019

    

2018

United States

$

27,288

 

87,150

 

74,028

Foreign

 

12,455

 

10,727

 

7,063

Total income before income taxes

$

39,743

 

97,877

 

81,091

The principal components of income tax expense (benefit) from continuing operations for 2020, 2019 and 2018 consist of:

(Dollars in thousands)

    

2020

    

2019

    

2018

Federal:

 

  

 

  

 

  

Current

$

10,982

 

13,888

 

7,663

Deferred

 

1,507

 

250

 

(22,329)

State and local:

 

 

 

Current

 

2,042

 

3,039

 

1,885

Deferred

 

(905)

 

98

 

2,899

Foreign:

 

 

 

Current

 

2,875

 

2,439

 

2,208

Deferred

 

(2,223)

 

674

 

2,504

Total

$

14,278

 

20,388

 

(5,170)

The actual income tax expense (benefit) from continuing operations for 2020, 2019 and 2018 differs from the expected tax expense for those years (computed by applying the U.S. Federal corporate statutory rate) as follows:

    

2020

    

2019

    

2018

 

Federal corporate statutory rate

    

21.0

%  

21.0

%  

24.5

%

State and local, net of Federal benefits

2.3

 

3.2

 

2.9

Foreign

(1.1)

 

0.6

 

0.8

Research credit

(3.4)

 

(0.8)

 

(1.6)

Domestic production deduction

 

 

(1.1)

Change in uncertain tax positions

 

(0.1)

 

(0.1)

Executive compensation

1.5

 

0.3

 

(0.1)

Valuation allowance

(6.3)

 

(2.4)

 

3.0

GILTI and FDII

0.4

(0.6)

Tax reform – impact on U.S. deferred tax assets and liabilities

 

(0.3)

 

(39.3)

Tax reform – transition tax

 

(0.1)

 

1.6

Tax reform – taxes related to foreign unremitted earnings

 

 

3.0

Pension plan termination charge

21.4

Other, net

0.1

 

 

Effective income tax rate

35.9

%  

20.8

%  

(6.4)

%

The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and liabilities at September 30, 2020 and 2019 are presented below:

(Dollars in thousands)

    

2020

    

2019

Deferred tax assets:

 

  

 

  

Inventories

$

4,998

 

4,800

Pension and other postretirement benefits

 

842

 

5,533

Timing differences related to revenue recognition

4,722

Lease liabilities

5,220

Net operating and capital loss carryforwards — domestic

 

563

 

602

Net operating loss carryforward — foreign

 

3,678

 

3,766

Other compensation-related costs and other cost accruals

 

8,953

 

7,764

State credit carryforward

 

2,366

 

1,914

Total deferred tax assets

 

31,342

 

24,379

 

 

Deferred tax liabilities:

 

 

Timing differences related to revenue recognition

(1,805)

ROU assets

(5,220)

Goodwill

 

(7,878)

 

(1,450)

Acquisition assets

 

(52,682)

 

(58,547)

Depreciation, software amortization

 

(21,283)

 

(18,288)

Net deferred tax liabilities before valuation allowance

 

(55,721)

 

(55,711)

Less valuation allowance

 

(1,932)

 

(4,504)

Net deferred tax liabilities

$

(57,653)

 

(60,215)

The Company has a foreign net operating loss (NOL) carryforward of $14.0 million at September 30, 2020, which reflects tax loss carryforwards in Germany, South Africa, Canada, India and the United Kingdom. Approximately $13.8 million of the tax loss carryforwards have no expiration date while the remaining $0.2 million will expire between 2028 and 2038. The Company has deferred tax assets related to state NOL carryforwards of $0.6 million at September 30, 2020 which expire between 2025 and 2040. The Company also has net state research and other credit carryforwards of $2.4 million of which $1.7 million expires between 2023 and 2035. The remaining $0.7 million does not have an expiration date.

The valuation allowance for deferred tax assets as of September 30, 2020 and 2019 was $1.9 million and $4.5 million, respectively. The net change in the total valuation allowance for each of the years ended September 30, 2020 and 2019 was a decrease of $2.6 million and a decrease of $2.6 million, respectively.The Company has established a valuation allowance against state credit carryforwards of $0.6 million and $0.4 million at September 30, 2020 and 2019, respectively. In addition, the Company has established a valuation allowance against state NOL carryforwards that are not expected to be realized in future periods of $0.5 million and $0.6 million at September 30, 2020 and 2019, respectively. Lastly, the Company has established a valuation allowance against certain NOL carryforwards in foreign jurisdictions which may not be realized in future periods of $0.8 million and $3.6 million at September 30, 2020 and 2019, respectively.

On December 22, 2017, the U.S. government enacted the Tax Cuts and Jobs Act, which made comprehensive changes to U.S. federal income tax laws by moving from a global to a modified territorial tax regime. As a result, cash repatriated to the U.S. is generally no longer subject to U.S. federal income tax. No provision is made for foreign withholding or any applicable U.S. income taxes on the undistributed earnings of non-U.S. subsidiaries where these earnings are considered indefinitely invested or otherwise retained for continuing international operations. Determination of the amount of taxes that might be paid on these undistributed earnings if eventually remitted is not practicable.